Company Description
Lifeward Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally.
It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals’ post-stroke.
The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors.
The company was formerly known as ReWalk Robotics Ltd. and changed its name to Lifeward Ltd. in September 2024.
Lifeward Ltd. was incorporated in 2001 and is based in Yokneam Illit, Israel.
| Country | Israel |
| Founded | 2001 |
| IPO Date | Sep 12, 2014 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 80 |
| CEO | William Grant |
Contact Details
Address: 3 Hatnufa Street, Floor 6 Yokneam Illit, 2069203 Israel | |
| Phone | 972 4 959 0123 |
| Website | golifeward.com |
Stock Details
| Ticker Symbol | LFWD |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001607962 |
| ISIN Number | IL0011331076 |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| William Mark Grant | President and Chief Executive Officer |
| Almog Adar | Chief Financial Officer |
| Jeannine Lynch | Vice President of Market Access and Strategy |
| Miri Pariente | Vice President of Operations, Regulatory and Quality |
| Judy Kula | Vice President of Customer Service, Human Resources and Business Affairs |
| Craig Peters DPT | Vice President of Sales - North America |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 2, 2026 | 8-K | Current Report |
| Feb 27, 2026 | 8-K | Current Report |
| Feb 25, 2026 | 8-K | Current Report |
| Feb 19, 2026 | 8-K | Current Report |
| Feb 9, 2026 | DEFM14A | Filing |
| Feb 9, 2026 | 8-K | Current Report |
| Jan 28, 2026 | PREM14A | Filing |
| Jan 28, 2026 | 8-K | Current Report |
| Jan 13, 2026 | 8-K | Current Report |
| Jan 6, 2026 | EFFECT | Notice of Effectiveness |